China Leflunomide Market (2025-2031) | Size & Revenue, Industry, Trends, Competitive Landscape, Segmentation, Analysis, Companies, Share, Growth, Value, Forecast, Outlook

Market Forecast By Trade Names (Arava, Lefumide, Arabloc, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) And Competitive Landscape
Product Code: ETC6746263 Publication Date: Sep 2024 Updated Date: Oct 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Dhaval Chaurasia No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

China Leflunomide Market Top 5 Importing Countries and Market Competition (HHI) Analysis

In 2024, China continues to import significant quantities of leflunomide, with top exporting countries being Ireland, Indonesia, UK, India, and Metropolitan France. Despite a negative compound annual growth rate (CAGR) of -6.23% from 2020 to 2024, there was a marginal growth rate of 0.01% in 2023-24. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market for leflunomide imports in China. It will be interesting to monitor how these trends evolve and impact the market dynamics in the coming years.

China Leflunomide Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

  • China Leflunomide Market Outlook
  • Market Size of China Leflunomide Market, 2024
  • Forecast of China Leflunomide Market, 2031
  • Historical Data and Forecast of China Leflunomide Revenues & Volume for the Period 2021- 2031
  • China Leflunomide Market Trend Evolution
  • China Leflunomide Market Drivers and Challenges
  • China Leflunomide Price Trends
  • China Leflunomide Porter's Five Forces
  • China Leflunomide Industry Life Cycle
  • Historical Data and Forecast of China Leflunomide Market Revenues & Volume By Trade Names for the Period 2021- 2031
  • Historical Data and Forecast of China Leflunomide Market Revenues & Volume By Arava for the Period 2021- 2031
  • Historical Data and Forecast of China Leflunomide Market Revenues & Volume By Lefumide for the Period 2021- 2031
  • Historical Data and Forecast of China Leflunomide Market Revenues & Volume By Arabloc for the Period 2021- 2031
  • Historical Data and Forecast of China Leflunomide Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of China Leflunomide Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of China Leflunomide Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of China Leflunomide Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of China Leflunomide Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
  • China Leflunomide Import Export Trade Statistics
  • Market Opportunity Assessment By Trade Names
  • Market Opportunity Assessment By Distribution Channel
  • China Leflunomide Top Companies Market Share
  • China Leflunomide Competitive Benchmarking By Technical and Operational Parameters
  • China Leflunomide Company Profiles
  • China Leflunomide Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the China Leflunomide Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the China Leflunomide Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 China Leflunomide Market Overview

3.1 China Country Macro Economic Indicators

3.2 China Leflunomide Market Revenues & Volume, 2021 & 2031F

3.3 China Leflunomide Market - Industry Life Cycle

3.4 China Leflunomide Market - Porter's Five Forces

3.5 China Leflunomide Market Revenues & Volume Share, By Trade Names, 2021 & 2031F

3.6 China Leflunomide Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 China Leflunomide Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Growing prevalence of autoimmune diseases in China

4.2.2 Increasing awareness about the benefits of leflunomide in treating rheumatoid arthritis

4.2.3 Favorable government initiatives supporting the healthcare sector in China

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for drug approval in China

4.3.2 High competition from alternative treatments for rheumatoid arthritis

4.3.3 Potential side effects and safety concerns associated with leflunomide

5 China Leflunomide Market Trends

6 China Leflunomide Market, By Types

6.1 China Leflunomide Market, By Trade Names

6.1.1 Overview and Analysis

6.1.2 China Leflunomide Market Revenues & Volume, By Trade Names, 2021- 2031F

6.1.3 China Leflunomide Market Revenues & Volume, By Arava, 2021- 2031F

6.1.4 China Leflunomide Market Revenues & Volume, By Lefumide, 2021- 2031F

6.1.5 China Leflunomide Market Revenues & Volume, By Arabloc, 2021- 2031F

6.1.6 China Leflunomide Market Revenues & Volume, By Others, 2021- 2031F

6.2 China Leflunomide Market, By Distribution Channel

6.2.1 Overview and Analysis

6.2.2 China Leflunomide Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.2.3 China Leflunomide Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.2.4 China Leflunomide Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

7 China Leflunomide Market Import-Export Trade Statistics

7.1 China Leflunomide Market Export to Major Countries

7.2 China Leflunomide Market Imports from Major Countries

8 China Leflunomide Market Key Performance Indicators

8.1 Number of new patients prescribed leflunomide

8.2 Rate of adoption of leflunomide as a treatment option

8.3 Patient satisfaction and adherence to leflunomide therapy

9 China Leflunomide Market - Opportunity Assessment

9.1 China Leflunomide Market Opportunity Assessment, By Trade Names, 2021 & 2031F

9.2 China Leflunomide Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 China Leflunomide Market - Competitive Landscape

10.1 China Leflunomide Market Revenue Share, By Companies, 2024

10.2 China Leflunomide Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All